APG Asset Management N.V. Has $225.687 Million Position in CME Group Inc (CME)

APG Asset Management N.V. raised its stake in shares of CME Group Inc (NASDAQ:CME) by 335.2% during the first quarter, according to its most recent 13F filing with the SEC. The fund owned 1,899,723 shares of the financial services provider’s stock after buying an additional 1,463,198 shares during the period. APG Asset Management N.V. owned 0.56% of CME Group worth $225,687,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Huntington National Bank increased its position in CME Group by 4.7% in the first quarter. Huntington National Bank now owns 851 shares of the financial services provider’s stock valued at $100,000 after buying an additional 38 shares during the period. Johnson Financial Group Inc. increased its position in CME Group by 5.9% in the fourth quarter. Johnson Financial Group Inc. now owns 899 shares of the financial services provider’s stock valued at $104,000 after buying an additional 50 shares during the period. Coconut Grove Bank increased its position in CME Group by 95.7% in the first quarter. Coconut Grove Bank now owns 900 shares of the financial services provider’s stock valued at $107,000 after buying an additional 440 shares during the period. Whittier Trust Co. increased its position in CME Group by 12.6% in the first quarter. Whittier Trust Co. now owns 1,030 shares of the financial services provider’s stock valued at $122,000 after buying an additional 115 shares during the period. Finally, Parallel Advisors LLC bought a new position in CME Group during the fourth quarter valued at approximately $120,000. 80.06% of the stock is currently owned by institutional investors.

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Shares of CME Group Inc (NASDAQ:CME) traded up 0.79% during midday trading on Friday, reaching $116.68. The company’s stock had a trading volume of 648,581 shares. CME Group Inc has a one year low of $92.29 and a one year high of $127.60. The company has a market capitalization of $39.65 billion, a P/E ratio of 25.26 and a beta of 0.88. The stock’s 50-day moving average is $117.48 and its 200-day moving average is $117.90.

CME Group (NASDAQ:CME) last released its quarterly earnings results on Thursday, April 27th. The financial services provider reported $1.22 EPS for the quarter, topping the consensus estimate of $1.20 by $0.02. CME Group had a return on equity of 7.28% and a net margin of 42.67%. The business had revenue of $929 million during the quarter, compared to analyst estimates of $932.06 million. During the same period last year, the business posted $1.15 earnings per share. The company’s quarterly revenue was down .5% on a year-over-year basis. On average, equities analysts expect that CME Group Inc will post $4.88 earnings per share for the current fiscal year.

TRADEMARK VIOLATION NOTICE: “APG Asset Management N.V. Has $225.687 Million Position in CME Group Inc (CME)” was originally published by Chaffey Breeze and is owned by of Chaffey Breeze. If you are accessing this story on another website, it was illegally copied and republished in violation of United States and international copyright laws. The correct version of this story can be viewed at https://www.chaffeybreeze.com/2017/05/19/cme-group-inc-cme-stake-raised-by-apg-asset-management-n-v-updated.html.

Several brokerages recently issued reports on CME. Royal Bank of Canada decreased their target price on CME Group from $134.00 to $133.00 and set an “outperform” rating on the stock in a research note on Wednesday, April 19th. Deutsche Bank AG lifted their target price on CME Group from $136.00 to $137.00 and gave the company a “buy” rating in a research note on Tuesday, April 18th. Zacks Investment Research downgraded CME Group from a “hold” rating to a “sell” rating in a research note on Wednesday, March 8th. Jefferies Group LLC restated a “buy” rating and set a $128.00 price target on shares of CME Group in a report on Saturday, March 11th. Finally, JPMorgan Chase & Co. cut CME Group from an “overweight” rating to a “neutral” rating in a report on Tuesday, January 31st. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and three have issued a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus target price of $111.90.

In other news, Director Ronald A. Pankau sold 500 shares of the stock in a transaction on Friday, February 24th. The stock was sold at an average price of $122.11, for a total value of $61,055.00. Following the sale, the director now directly owns 3,500 shares in the company, valued at $427,385. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Dennis Suskind sold 1,099 shares of the stock in a transaction on Friday, April 28th. The shares were sold at an average price of $115.29, for a total value of $126,703.71. Following the completion of the sale, the director now owns 5,000 shares in the company, valued at $576,450. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 13,030 shares of company stock valued at $1,581,964. Company insiders own 0.61% of the company’s stock.

CME Group Company Profile

CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.

5 Day Chart for NASDAQ:CME

Receive News & Ratings for CME Group Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply